Loading...
Market
Will the court rule in favor of Vertex Pharmaceuticals in the Casgevy gene therapy fertility support program lawsuit by the end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official court records or press releases from Vertex Pharmaceuticals or the US Department of Health and Human Services
Story
Vertex Pharmaceuticals Sues US Government Over Casgevy Gene Therapy Fertility Support Program
Jul 15, 2024, 06:12 PM
On July 15, Vertex Pharmaceuticals filed a lawsuit against the US government, specifically the US Department of Health and Human Services, seeking a court declaration that a fertility support program for patients prescribed its gene editing therapy, Casgevy, does not violate federal anti-kickback laws. The company is requesting permission to pay for fertility treatment for individuals who receive the Casgevy gene therapy, which can interfere with reproduction.
View original story
Similar markets
Yes • 50%
No • 50%
Vertex wins • 25%
HHS wins • 25%
Settlement reached • 25%
Case dismissed • 25%
Yes • 50%
No • 50%
Vertex allowed to pay for fertility treatment • 25%
Vertex not allowed to pay for fertility treatment • 25%
Settlement with conditions • 25%
Case unresolved • 25%
Does not violate • 25%
Violates • 25%
Partially violates • 25%
No ruling • 25%
Yes • 50%
No • 50%
In Favor of Screening • 25%
Against Screening • 25%
Settlement Reached • 25%
Case Dismissed • 25%
Yes • 50%
No • 50%
Roche wins • 25%
Stanford and Foresight win • 25%
Settlement reached • 25%
Case dismissed • 25%
Appeal denied • 25%
Appeal granted • 25%
Settlement reached • 25%
Case withdrawn • 25%
